Project Grant HT94252510619
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$848K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
This federal Project Grant award for $772,501.00, awarded on May 1, 2024 by the Defense Health Agency, supports the University of Nebraska Medical Center's research project titled "BUTYRYLCHOLINESTERASE: AN OUTSTANDING DIAGNOSTIC AND DRUGGABLE BIOMARKER IN UVEAL MELANOMA." The project, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance research into butyrylcholinesterase as a diagnostic and therapeutic target for uveal melanoma, a rare and...
This federal Project Grant award of $183,220.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Nebraska Medical Center (UNMC) to target the CCL17/CCR4 axis to eradicate lung cancer brain metastasis. The award, which began on February 1, 2025 and will be completed by January 31, 2026, aims to advance biomedical research that transforms healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
The federal Project Grant award of $3,120,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Thomas Jefferson University's Sidney Kimmel Medical College on novel tumor-targeted immunotherapies against metastatic uveal melanoma. This 4-year award, running from September 1, 2025 to August 31, 2029, aims to transform healthcare for military service members, veterans, and the broader public through innovative...
The U.S. Department of Defense's Defense Health Agency awarded a $393,416 Project Grant to the Board of Regents of the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2026, will support UNMC's research on the "Influence of Ocular Blast Injury on Retinal Output Synapses in the Brain". This project aims to advance the understanding of the...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...